Shirley, NY, 2023-Nov-28 — /EPR Network/ — BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissman for being recipients of the 2023 Nobel Prize [read full press release…]
Amsterdam, Netherland, 2023-Oct-21 — /EPR Network/ — BOC Sciences will attend “TIDES Europe: Oligonucleotide & Peptide Therapeutics”, delivered as a hybrid event from 30 Oct – 1 [read full press release…]
“End-to-End Support for Your Pharmaceutical Journey”, with the commitment to researchers, BOC Sciences will attend the renowned World Vaccine Congress Europe in Barcelona, Spain, from 16 to 19 October. [read full press release…]
Shirley, NY, 2023-Aug-21 — /EPR Network/ — BOC Sciences, a leading supplier of research chemicals and custom services, has unveiled its innovative XDC bioconjugation platform, providing [read full press release…]
New York, USA, 2023-Jul-16 — /EPR Network/ — BOC Sciences is honored to say its professional PEG support has expedited the R&D of universities, research [read full press release…]
New York, USA, 2023-Jul-16 — /EPR Network/ — Average drug-to-antibody ratio (DAR) and drug load distribution are two vital properties of antibody drug conjugates (ADCs). Over the years, [read full press release…]
New York, USA, 2023-Jul-16 — /EPR Network/ — BOC Sciences confirms that its global factories are able to manufacture various oligosaccharides in bulk to meet [read full press release…]
New York, United States, 2023-May-12 — /EPR Network/ —BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate [read full press release…]
Shirley, NY, 2023-Feb-09 — /EPR Network/ — Professor Shiyue Fang from the Department of Chemistry, Michigan Technological University, accepted BOC Sciences’ invitation to present his insightful ideas about sensitive nucleic acid applications [read full press release…]
New York, USA, 2023-Jan-04 — /EPR Network/ — The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody [read full press release…]
New York, USA, 2023-Jan-04 — /EPR Network/ — BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade [read full press release…]
Shirley, NY, 2022-Nov-24 — /EPR Network/ — Towards the end of 2022, BOC Sciences introduced its metabolite manufacturing abilities, particularly the production of Aureobasidin A for [read full press release…]
Shirley, NY, 2022-Nov-24 — /EPR Network/ — It’s verified by BOC Sciences officials that the critical specialty chemical distearyl phthalic acid amide is now in [read full press release…]
New York, USA, 2022-Nov-02 — /EPR Network/ — BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. [read full press release…]
New York, USA, 2022-Nov-02 — /EPR Network/ — BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is [read full press release…]
New York, USA, 2022-Nov-02 — /EPR Network/ — Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the [read full press release…]
New York, USA, 2022-Nov-02 — /EPR Network/ — BOC Sciences announces support for antibody–drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization [read full press release…]
New York, United States, 2022-Oct-17 — /EPR Network/ — Managing raw materials as part of the quality system will ensure that all finished healthcare products [read full press release…]
Shirley, NY, 2022-Oct-17 — /EPR Network/ — BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG [read full press release…]
Shirley, NY, 2022-Oct-17 — /EPR Network/ — BOC Sciences recently confirmed to its customers that over 10,000 impurities are now in stock, ready for immediate [read full press release…]
